Skip to content

Diagnostics
Lab Services & Imaging

Our state-of-the-art diagnostic services consist of seven laboratories including the first Molecular Cancer Diagnostics laboratory in Bangladesh as well as comprehensive imaging exams.

Praava Health - Lab test

Lab Services

Laboratory testing is important for diagnosing and helping to manage health conditions. These might include blood tests, tests requiring samples of your urine or stool, and other services such as Pap tests and biopsies. Lab testing may be part of a routine check-up, help your doctor make a diagnosis, or be necessary for monitoring health conditions. If you have a chronic condition such as high cholesterol or diabetes, your doctor may ask you to come in regularly for tests to monitor your health. You may also request certain services yourself, such as screening for sexually transmitted infections.

Praava’s full range of on-site lab services include the following laboratories:

  • Biochemistry & Immunochemistry
  • Microbiology & Serology
  • Hematology & Coagulation
  • Histopathology & Cytopathology
  • Immunohistochemistry
  • Clinical Pathology
  • Molecular Cancer Diagnostics

In addition, we offer home sample collection including blood and urine samples.

Imaging

Praava’s family health center is equipped with state-of-the-art imaging and radiology equipment from the world’s best manufacturers.

Our imaging services include:

  • X-Ray
  • Ultrasonography
  • Mammography
  • ECG
  • Holter ECG
  • ETT
  • Teleradiology
  • Intravenous Urogram (IVU)
  • Retrograde Urethrogram (RGU)
  • Micturating Cysto-Urethrogram (MCU)
  • Retrograde Urethrogram (RGU) & Micturating Cysto-Urethrogram (MCU)

Your scans will be permanently stored in our Radiology Information System (RIS), which you will be able to access from our Patient Portal using your laptop or mobile phone.

We are also incorporating a Teleradiology Picture Archiving and Communication System (PACS) to allow us to access a network of international radiologists (including US board-certified radiologists) to provide second opinions on diagnoses of your scans.

Diagnostic Services, Diagnostic Services

Our Sample Collection Points Across Dhaka

Select Area

Collection Point-Kabir’s Health Care

Sec-2, Block A, Avenue-1, House 24, Mirpur, Dhaka – 1216

11am to 2pm & 6pm to 10pm

+8801911969740

Dactar Bari

12/D, 29/25, Pallabi, Mirpur, Dhaka 1216

6pm to 10pm

+8801723146136

Kuril (COVID Sample Collection)

Ka-62, Kuril Chowrasta, Kuril, Dhaka-1219

10am – 5pm

Maa Pharmacy

47, Horirumpur (Near Lotun Vila), Mirpur-1, Dhaka – 1216

11am to 10pm

+8801972148765

Mirpur (COVID Sample Collection)

2-F, Road 7, Love Road, Mirpur 2, Dhaka

10am – 5pm

Mohammadpur (COVID Sample Collection)

Modina villa-3, Flat no-A1, House-09, Road-1, Char Rasta, Chadd Uddan, Mohammadpur, Dhaka-1207

10am – 5pm

New Popular Pharmacy

Banani, Dhaka -1213

10am to 1pm & 6pm to 11pm

+8801685101919

Prescription Care

Ka-62, Kuril Chowrasta, Kuril, Dhaka-1229

8am to 1pm & 4.30pm to 12am

+8801928275286

Uttara (COVID Sample Collection)

38 Shahjalal Avenue, Sector 04, Uttara, Dhaka

10am – 5pm

Molecular Cancer Diagnostics

Molecular cancer diagnostics are tests that detect genetic material or related molecules that provide specific information on the disease. The tests are mostly run on blood or tissue samples. Genetic changes are detected on DNA/RNA isolated from patient tissue samples. Molecular cancer diagnostics tests are mainly done on patients who are already diagnosed with some form of cancer.

Benefits of Molecular Cancer Diagnostics: 

  • Helps to identify very specific treatment
  • Reduces the number of unnecessary tests or therapy
  • Helps to understand whether a patient has become resistant to the therapy or medication prescribed 
  • Helps to prolong life span of patients who are at the last stage of cancer by providing information about possible therapies
CALL: 10648

Praava’s Cancer Diagnostic Tests

Praava’s Molecular Cancer Diagnostics lab is a state-of-the-art facility for screening and diagnosis of cancer in Bangladesh. We are focused on early detection of colorectal, breast, cervical, and lung cancers to allow for their appropriate diagnosis and treatment.

Colorectal Cancer

Colorectal cancer occurs in the colon or rectum. The cancer, when discovered early, is highly treatable. Even if it spreads to nearby regions surgical treatment followed by chemotherapy is highly effective.

  • Real-time PCR assay to detect seven mutations in the KRAS gene
  • KRAS Seven Mutations Detection profile is a sensitive and selective assay for the detection of the most common somatic mutations in the KRAS gene. This test amplifies exon 2 of K-RAS gene associated with colorectal cancer and its precursor lesions. Mutations in KRAS codons 12 and 13 have been associated with lack of response to EGFR-targeted therapies in CRC patients (>93%). Absence of mutation predicts greater sensitivity to EGFR-targeted therapies and improved survival.
  • Single Test: KRAS mutation detection to guide anti-EGFR therapy
  • Profile:Fecal occult blood/FIT, Septin 9 gene methylation by PCR

Breast Cancer

  • HER2/neu gene amplification in human tumor tissue
  • This test amplifies HER2 gene, predicting responsiveness to trastuzumab therapy. Positive result (amplification of HER2) predicts responsiveness to trastuzumab therapy. Samples negative and positive for HER2 overamplification can readily be discriminated. The results achieved are unambiguous and comparable between runs and individual samples. This real-time quantitative PCR test offers a rapid detection method for HER2 DNA overamplification in breast tissue samples.
  • Single Test: HER2 gene amplification to confirm IHC/FISH results performed elsewhere.
  • Profile:Mammography, HER2 gene amplification test, ER/PR test.

Cervical Cancer

  • Real-time PCR assay for high-risk Human Papillomavirus (HPV) detection
  • Human papillomavirus (HPV) is a sexually transmitted DNA virus that establishes infection in squamous epithelial cells in the human body. High-risk HPV infection is necessary for the development of cancers of the uterine cervix, which has been firmly established. Approximately 99.7% of cervical cancers are caused by high-risk HPV infection. In particular, HPV16 and HPV18 are known to cause around 70% of cervical cancer cases.
  • Single Test: HPV16/18 genotyping.
  • Profile:HPV16/18 genotyping, PAP test, CT, MRI.

Lung Cancer (Non-Small Cell Lung Cancer-NSCLC)

  • EGFR mutation by real-time PCR
  • For patients who may receive anti-EGFR monoclonal antibodies (e.g. cetuximab, panitumumab) or tyrosine kinase inhibitors (e.g. erlotinib).
  • This test amplifies deletion in exon 19 and / or a mutation in exon 21 (L858R), EGFR gene associated with non-small cell lung cancer (NSCLC) and its precursor lesions. Mutations in EGFR have been associated with lack of response to EGFR-targeted therapies in NSCLC patients (>93%). Absence of mutation predicts greater sensitivity to EGFR targeted therapies and improved survival. Vast majority of patients receiving TKI therapy will develop resistance and may acquire exon 20 T790M mutation. Since inhibitors against this mutation are available, we will also test for EGFR T790M mutation in a separate assay.
  • Single Test 1: EGFR.
  • Single Test 2: ALK.
  • Single Test 3: ROS1.
  • Single Test 4: BRAF.
  • Profile 1:Mutation detection.
  • Panel: EGFR; ALK; ROS1; BRAF.

Septin 9 Liquid Biopsy

  • Septin 9 liquid biopsy is a molecular test that detects methylated Septin 9 DNA in blood. DNA methylation of the Septin 9 gene is increased in colorectal cancer. Methylated Septin 9 DNA can be found in tumor DNA that has been shed and this plasma-based test requires no patient preparation. The test may be ordered for screen-eligible patients who have avoided routine colorectal cancer screening methods such as colonoscopy, fecal occult blood tests, and fecal immunochemical tests (FITs). The test uses polymerase chain reaction (PCR) for the methylation specific detection of the Septin 9 DNA target. The Septin 9 test results, together with the physician’s assessment of history, other risk factors, and professional guidelines, may be used to guide patient management. Patients with a positive test result should be referred for diagnostic colonoscopy.

Routine Tumor Marker Profiles

  • Tumor Profile-Female (TPF)
    • AFP, CEA, CA 15.3, CA 19.9, CA 125, b-HCG
  • Tumor Profile-Male (TPF)
    • PSA, Free-PSA, AFP, CEA, CA 19.9, b-HCG

Diagnostics Planning For What’s Next

Praava Health will continue to follow the latest news and technologies and bring the highest quality treatment options to our Patients. We are committed to using the latest diagnostic technology for early detection and treatment of cancer.

Request a Call Back

We can call you back

Please join our newsletter to avail 10% discount on our lab services. Terms and conditions apply.